Skip to content

Lexicon Pharmaceuticals LXRX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$26.09M+48.2%-$50.34M+26.6%-$68.58M+43.1%-$120.62M+32.0%-$177.3M+11.5%
$555K-10.6%$621K-1.1%$628K+4.1%$603K+6.5%$566K+6.0%
$12.55M+0.3%$12.52M+11.6%$11.22M+6.1%$10.58M-13.6%$12.24M-9.3%
-$167.43M+6.3%
$2.18M-98.1%$113.02M
$53M+10.4%$48M+6.7%$45M0.0%$45M
$40.83M+184%-$48.5M
$4.2M+226%-$3.33M-108%$44.11M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Lexicon Pharmaceuticals generate?
Lexicon Pharmaceuticals (LXRX) generated -$99.6M in operating cash flow over the trailing twelve months.
Where does Lexicon Pharmaceuticals's cash flow data come from?
Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.